Highlights from Laboratoires Théa’s Satellite Education Program, “Ocular Surface: What’s New?” held on October 8, 2015, at the 7th EVER Congress, Nice, France.

You might want to do the right thing and get stuck in – but there’s a bigger picture to be seen before you do.

What does analysis of the last five years of literature on endophthalmitis tell us about the priorities of the field, and the contributors to it?

Big data EMR mining (and some basic research) identifies a 50-year old drug that appears to protect against AMD development

Preservatives in topical glaucoma therapy: they risk ocular surface disease and future filtration surgery failure, and do nothing to improve efficacy. Is it time to leave them behind?

In eye care, anyone with an idea can make a difference

Showcasing the greatest ophthalmic advances of the year

The Greek bailouts came with a price: austerity. This might come to pass as a highly myopic move. We explore its impact on ophthalmology – and the future health economic toll it will take on Greek society.

Why is public awareness of dry eye so disturbingly low, and what can be done to change this?

AMD is the leading cause of blindness in developed countries, and the third-leading cause in developing countries.